Spur Therapeutics Alternatives & Competitors

7 companies similar to Spur Therapeutics — Toward the next generation of gene therapy.

Taysha Gene Therapies

Taysha Gene Therapies is focused on advancing AAV-based gene therapies for severe monogeni...

134 IPO $802.30M

Dallas, United States

Biotechnology Life Sciences

Compare

Exegenesis Bio

We are reimagining ways to develop & manufacture gene therapies. Our mission is to improv...

17 Series B

Philadelphia, United Stat...

Biotechnology Health Care +1

Compare

Spark Therapeutics, Inc.

This company is now integrated into the Roche Group, united in our commitment to do now wh...

304 Acquired $5.22B

Philadelphia, United Stat...

Biotechnology Health and Wellness

Compare

Vivet Therapeutics

Vivet Therapeutics develops gene therapy treatments for inherited liver disorders using li...

16 Grant $87.40M

Paris, France

Biopharma Biotechnology +1

Rival Readout

Competing with Spur Therapeutics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

AAVantgarde

Pioneering treatments for Stargardt disease and Usher 1B, addressing the root cause of the...

70 Series A

Biotechnology Health Care +1

AVROBIO

Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring perso...

16 Acquired $110.00M

Cambridge, United States

Biotechnology Health Care

MiNA Therapeutics

Activating RNA, mastering disease

34 Corporate Round $73.00M

London, United Kingdom

Biotechnology Life Sciences +1

About Spur Therapeutics

Freeline is a biopharmaceutical company focused on developing liver-directed gene therapies for inherited systemic diseases. With clinical programs for Hemophilia B and Fabry disease, and preclinical programs in Gaucher disease and haemophilia A, the company aims to revolutionize treatment options for individuals suffe...

Business keywords

Gene Therapy, Liver-directed, Inherited Diseases, Clinical Trials, AAV-based Therapy, Hemophilia B, Fabry Disease, Gaucher Disease, Haemophilia A, Innovation, Global Locations, Systemic Diseases, United Kingdom, United States

Frequently Asked Questions

Companies similar to Spur Therapeutics include Taysha Gene Therapies, Exegenesis Bio, Spark Therapeutics, Inc., Vivet Therapeutics, AAVantgarde. They work in Biotechnology and Health Care and share Spur Therapeutics's focus on gene therapy, hemophilia b and gaucher disease.

Bounce Watch lists 7 companies that share Spur Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Spur Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Spur Therapeutics Profile Taysha Gene Therapies Alternatives Exegenesis Bio Alternatives Spark Therapeutics, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Spur Therapeutics on 11 Sep 2024. The 7 companies listed here were last checked between 11 Sep 2024 and 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.